In general, an implantable medical device is disclosed for generating and applying an electric stimulation signal to a portion of a patient's gastrointestinal tract to induce symptoms of gastroparesis in the patient without substantially reducing normal stomach motility. The induced symptoms of gastroparesis may reduce a patient's desire to consume large portions of food and thus provide an effective treatment for obesity.